• Product NameCarvedilol phosphate
• Brief DescriptionInhibitors
• Purification99.50%
• Biological ActivityCarvedilol is a non-selective beta blocker indicated in the treatment of mild to moderate congestive heart failure (CHF). It blocks beta-1 and beta-2 adrenergic receptors as well as the alpha-1 adrenergic receptors.
• Target NameAdrenergic Receptor antagonist; Gap Junction Protein inhibitor; Integrin inhibitor; NADPH inhibitor; Others inhibitor; Potassium Channel inhibitor; VEGFR inhibitor
• CAS No. 610309-89-2
• Calculated MW 522.49
• Formulation C24H26N2O4H2OH3O4P
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Other
  SMILES:O.OP(O)(O)=O.COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2
  Pathways:Neuroscience; Angiogenesis; Cytoskeletal Signaling; Membrane transporter/Ion channel; Metabolism; Others; GPCR/G Protein; Tyrosine Kinase/Adaptors
  Receptor:Adrenergic Receptor; Gap Junction Protein; E-selectin; NADPH dehydrogenase; Natriuretic peptides B; VCAM1; Potassium Channel; VEGFR
  Boling pt:655.2C
  Melting pt:
  Solubility:Water: 10 mM
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Nichols AJ, et al. Fundam Clin Pharmacol. 1991;5(1):25-38.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting